Smoking Cessation CM for Veterans With or at Risk for Cancer

Prior treatment

• Never smokers or quit smoking for longer than 36 months prior to consent (4) no access to Wi-Fi or devices that support audio and video communication
  • VA Clinical Staff:
• A suicide attempt or suicidal ideation with intent in the 30 days prior to enrollment
• Concurrent enrollment in a tobacco cessation clinical trial

Other illness

• Current severe, untreated mental illness (i.e., psychosis, bipolar disorder, and/or substance use disorder (SUD) and/or
• Psychotic disorders, bipolar disorder, neurocognitive disorder, substance use disorders, or other psychiatric or medical conditions judged by the PI to be unstable in the past 30 days, based on screening results and/or medical record review, including conditions for which large sums of money would be potentially destabilizing
• Metastatic cancer or enrollment in end of life/ palliative care

Age

• Currently pregnant or planning to become pregnant during the study (people of childbearing potential ages 18-55 who are pregnant or state that they plan to become pregnant during the study)

Other

• Focus Groups: For Focus Groups (Year 1), the investigators will recruit both Veterans and VA clinical staff at SFVAHCS.
• Veterans:
• Current (past 30 days) active suicidal/homicidal ideation or severe behavioral instability that would prevent participation
• Unable to commit approximately 45-60 minutes (approx. 30-60 mins focus group/interview and self-report questionnaires)
  • Pilot Feasibility Study (Year 2) and Randomized Controlled Trial
• An individual who meets any of the following criteria will be excluded from participation in this study:
• Evaluated by investigative team medical record review and clinical assessment:
• Untreated, current, active problem gambling, assessed by medical record diagnosis and/ or Problem Gambling Severity Index (PGSI) score 8
• Unable to commit to time commitment required for participation

• In order to be eligible to participate in this study, an individual must meet all of the following criteria:
• Human Subjects Involvement and Characteristics: This Proof of Concept and Clinical Trial has three stages. The Proof-of-Concept Phase (Years 1-2) includes a Focus Group phase (Year 1) in which the investigators will recruit both Veterans and non-Veterans (VA clinical staff); and a Pilot Study (Year 2) in which the investigators will recruit Veterans in LCS or cancer treatment at San Francisco VA Healthcare System (SFVAHCS). If the Pilot Study is successful, the investigators will recruit Veterans in lung cancer screening (LCS) or cancer treatment for the RCT (Years 3-6).
• Focus Groups: For Focus Groups (Year 1), the investigators will recruit both Veterans and VA clinical staff at SFVAHCS.
  • Veterans:
• Veteran eligible for VA healthcare
• English-speaking
• Received SFVAHCS cancer monitoring or treatment or lung cancer screening (LCS) within the past 24 months
• Active cigarette smoking within the past 24 months
• Have access to Wi-Fi and a device that supports audio and video communication
  • VA Clinical Staff:
• Current member of clinical staff at the SFVAHCS
• Have participated in the care of at least 5 VA cancer or LCS patients in the past 6 months
  • Pilot Feasibility Study (Year 2) and Randomized Controlled Trial
• Veteran currently receiving medical care at SFVAHCS (at least one clinical visit same calendar year for cancer)
• English-speaking
• Current, active (same calendar year) enrollment in VA LCS, or current (same calendar year) diagnosis of cancer documented in the VA medical record, confirmed through medical record review
• Current (past 30 days) cigarette smoking a minimum of 1 cigarette per day (average), assessed by Timeline Followback (TLFB)92, 99-101
• Open to receiving smoking cessation interventions